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Abstract
Significant controversy has existed in the areas of
management of women with cervical cytological diagnoses of
atypical squamous cells of undetermined significance (ASCUS)
and ASCUS suggestive of human papillomavirus (HPV). The
purpose of this study was to determine the incidence of
cervical dysplasia in women with and without cytology
suggestive of HPV in order to improve patient management.
The Bethesda System was utilized as the basis for a
conceptual physiological framework. Orem's self-care theory
was shown to support the framework. The researcher
hypothesized that there would be no difference in the
incidence of cervical dysplasia in women with cytology
suggestive of HPV and women without cytology suggestive of
HPV. This retrospective study utilized a convenience sample
(N = 58) drawn from a population consisting of records of
women (N = 442) with cytology reported as ASCUS from an area
in the southeastern United States. Descriptive and
inferential statistics were employed for data analysis.
Descriptive statistics confirmed an incidence of cervical
dysplasia in women with ASCUS (n = 42) of 30.95% and an
incidence of cervical dysplasia in women with ASCUS
suggestive of HPV (n = 16) of 18.75%. This finding
iv

represents a 65% higher incidence of cervical dysplasia in
the women with Pap reports of ASCUS without evidence of HPV.
Utilizing contingency tables and chi-square analysis, no
significant difference between the two subsets and the
incidence of dysplasia emerged, X^(l, N = 58) = 0.8629,
p < .05, p = 0.353. Therefore, the researcher concluded no
difference in the incidence of cervical dysplasia in women
with cytology reports of ASCUS and women with cytology
reports of ASCUS suggestive of HPV existed and accepted the
null hypothesis. Findings indicated the need for further
research and closer monitoring of patients with cytologic
diagnosis of ASCUS and ASCUS suggestive of HPV. Nurse
practitioners must assume responsibility to conduct research
in the area of ASCUS and ASCUS suggestive of HPV to extend
theory and knowledge while functioning as primary care
providers for women. Management of cytology reports will be
an important component of clinical practice and involve
intervention, educative and supportive nursing functions.
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Chapter I
The Research Problem
Significant controversy has existed in the areas of
management of women with a cytological diagnosis of atypical
squamous cells of undetermined significance (ASCUS)

(ACOG

Technical Bulletin, 1993; Schaffer & Philput, 1992; Slawson,
Bennett, & Herman, 1993) and women with the diagnosis of
ASCUS suggestive of human papillomavirus (HPV)

(American

College of Obstetricians and Gynecologists, 1994; Kurman,
Henson, Herbst, Noller, & Schiffman, 1994; Schaffer &
Philput, 1992). Gaining additional knowledge regarding the
incidence of progression of ASCUS to cervical dysplasia will
have provided more direction in the management of women with
ASCUS and ASCUS suggestive of HPV. The purpose of this study
was to determine the incidence of cervical dysplasia in
women with and without cytology suggestive of HPV in order
to provide improved and appropriate management to women with
ASCUS.
Further controversy has existed in the area of cervical
cytology. While the Papanicolaou (Pap) smear has remained
the most successful screening tool for cervical cell
abnormalities, refinements in diagnosing cervical cytology
have continued. Terminology used to define gradations of
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cervical disease, classifications to describe test results,
and appropriate techniques for collecting adequate cervical
cell specimens have been targeted for change (Fowler, 1993).
The Bethesda System has remained the accepted standard for
cervical cytology diagnosis since the early 1990's .
Establishment of the Problem
One of the major classifications of The Bethesda System
scrutinized has been that of atypical squamous cells of
undetermined significance (ASCUS). Kurman and Solomon (1994)
indicated ASCUS results reflected either an exuberant benign
change or a potentially serious lesion, and, therefore, were
interpreted to be of undetermined significance. Abdul-Karim
and Willis (1994) reported numerous studies attempted to
determine the biological significance of atypical squamous
cells without much consistency.
The available data indicate that for many
specimens demonstrating ASCUS, patients do not
have a significant lesion, and follow-up smears or
colposcopic biopsies are normal. In a proportion
of patients, however, the abnormality will persist
and in a significant number of these, further
evaluation will detect a squamous intraepithélial
lesion. (Kurman & Solomon, 1994, p. 42)
Significant controversy has existed in the management
of women with ASCUS. Guidelines for management established
by the American College of Obstetricians and Gynecologists
(ACOG) were presented in the ACOG Technical Bulletin of
August 1993. If the patient with cytological diagnosis of
ASCUS was determined to be reliable, she could be scheduled
to return for repeat Pap smears every six months.
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Recommendation was for colposcopic examination after two or
more cervical cytology reports of ASCUS. With a potentially
non-compliant patient, initial colposcopy was recommended
for consideration. Conversely, Schaffer and Philput (1992)
suggested a decision for management be based on the
patient's resources and history while Slawson, Bennett, and
Herman (1993) recommended immediate colposcopy for atypical
smears.
Another dilemma was the diagnosis of ASCUS suggestive
of human papillomavirus (HPV) on cervical cytology smears.
HPV has been recognized as being highly prevalent in the
general population and spread through sexual contact
(Morrison, 1994). The possibility of HPV opened a whole new
arena for exploration. Of initial importance was, according
to Dr. V. Cecil Wright, the latency period of HPV after
exposure which may range from six weeks to twenty years
(personal communication, December 4, 1994). In 1992,
Schaffer and Philput reported there was no documentation of
the risk of latent HPV progression over time. Even so, ACOG
(1993)

reported that women with HPV were at increased risk

for preinvasive cervical lesions. ACOG also reported that a
progression to high grade squamous intraepithélial lesion
(SIL) occurred in approximately 15% of women with HPV and
that spontaneous regression occurred in approximately 60%.
ACOG did not propose the outcomes of the other approximate
25%. High rates of false negative results have indicated the
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need for histologic confirmation. Low grade SIL, which
included HPV, and ASCUS classifications represented,
according to Kurman, Henson, Herbst, Noller, and Schiffman
(1994), the greatest problem for the clinician from the
standpoint of management and the largest volume of patients
that required evaluation. Not surprisingly, controversy over
management of these findings also has existed.
ASCUS suggestive of HPV had cytologic changes that when
observed could possibly have been related to the type of HPV
infection. Thus colposcopic examination proved helpful in
the increased rate of detection of HPV. Management of ASCUS
suggestive of HPV, however, and controversies surrounding
the diagnosis, remained similar to those of ASCUS (AbdulKarim & Willis, 1994).
There has been substantial controversy in the
management of women with atypical squamous cells because of
the identification of undetermined significance. Some
literature suggested practitioners watch and wait while
others supported an aggressive approach which utilized
immediate colposcopy for diagnostic determination. Kline and
Kannan (1994) indicated the need to further study the
biologic behavior of ASCUS. Due to frequent changes in
cytology reporting, inconsistencies between reportings, and
lack of current literature, further investigation was
necessary.

5

Significance to Nursing
As the incidence of cervical dysplasia in women with
and without cytology suggestive of HPV has been quantified,
additional information has been added to the body of
existing knowledge in nursing as well as other medical
fields. Research, along with improved and consistent
management of women with ASCUS, has strengthened not only
the role of the nurse practitioner, but has also contributed
to the current body of scientific research in the areas of
ASCUS and ASCUS suggestive of HPV. This study quantified the
incidence of cervical dysplasia and therefore has
strengthened the support for specific guidelines for
management of patients with cervical cytologic ASCUS
classification. Nurse practitioners have the responsibility
to provide supportive and educative services to their
clients. This research will benefit practitioners' services
by strengthening the scientific body of knowledge in
management of women with Pap smear reports of ASCUS and
ASCUS suggestive of HPV by determining the incidence of
subsequent cervical dysplasia. Not only compliance but
timely follow-up has been indicated to optimize the outcomes
of these patients. As nurse practitioners' roles expand in
the primary care arena, nurse practitioners must assume
greater responsibility for management of women with abnormal
cytology.

6

Physiological Conceptual Framework
The Bethesda System served as the basic physiological
framework of this research to facilitate the
conceptualization of the study and support the contributing
information. Dorothea Orem's self-care theory supported
women's measures in obtaining cervical screening and followup as well as the nurse practitioner role in their
management.
The Bethesda System was adopted in December 1988 to
promote communication between the laboratory and the
clinician by providing uniform diagnostic terminology. The
design of The Bethesda System was to facilitate
categorization and reporting of cytologic diagnoses. The
cytologic diagnosis was based on the most abnormal cells
present on a smear (Kurman & Solomon, 1994)

(see Appendix A

for the complete Bethesda System).
The Bethesda System was amended and modified in April
1991. It was emphasized that The Bethesda System was only a
recommended terminology not specifically mandated by
legislation. Use of traditional terminology was still
acceptable for use in conjunction with The Bethesda System
(see Appendix B for terminology comparisons between
classification systems). The predominant strength of The
Bethesda System identified by Fowler was the use of
terminology that closely followed the histopathologic
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vocabulary utilized in reporting cervical cytologic
diagnoses (Valente & Shantz, 1993).
Specimen adequacy held high priority at the second
Bethesda conference held in 1991. Specimen adequacy was
correlated to collection of both squamous epithelium cells
and squamous metaplastic cells. Columnar and squamous
epithelium comprise the cervix. The cervical transformation
zone, an area of change, was identified as an area of
squamous metaplasia. Squamous metaplasia was defined as the
process by which columnar cells evolve into squamous cells,
and mature squamous epithelium occurs when the tips of
columnar papillae grow together (Rubin & Lauver, 1990). A
fully satisfactory Pap smear included cell samples of
squamous epithelium cells and squamous metaplastic cells and
was correlated with specimen adequacy. The cells were most
easily sampled using a Cytobrush and Ayre wooden spatula.
The Pap smear was not promoted as a diagnostic tool, but
specificity was reported to be high if the results were
positive (Buck, 1994).
Other sections of The Bethesda System included general
categorization, which was optional, and descriptive
diagnoses. Epithelial cell abnormalities included ASCUS. The
Bethesda System reports had to qualify ASCUS as to whether a
reactive or prema1ignant (suggestive of HPV) or even a
malignant process was favored. The specimen adequacy was
considered along with the Pap smear results. Appropriate
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management was supported based on the adequacy of the
specimen and the cervical cytology results. Management also
was aided by the consistency of reporting— the descriptive
diagnoses, and the criteria for interpretation as was
outlined in The Bethesda System (Valente & Schantz, 1993).
While the physiologic framework of this study was
developed around The Bethesda System, the theoretical
framework was developed utilizing Dorthea E. Orem's SelfCare Deficit Theory of Nursing. Orem (1991) acknowledged her
theory as a general theory composed of three related
theories. The first was the theory of self-care in which
self-care was described and explained:
Self-care is learned, goal-oriented activity of
individuals. It is behavior that exists in
concrete life situations directed by persons to
self or to the environment to regulate factors
that affect their own development and functioning
in the interests of life, health, or well-being.
(Orem, 1991, p. 64)
Orem's second theory, the theory of self-care deficit,
described and explained why people can be helped through
nursing. The theory of nursing systems was Orem's third
theory. In her theory of nursing systems, Orem described and
explained relationships that must be brought about and
maintained for nursing to occur (Orem, 1991).
Orem's (1991) theory of self-care related directly to
women seeking Pap smear screening. Self-care requisites
fostered health and well-being. The role of the nurse
practitioner in providing information and explanations to
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facilitate knowledge of an illness or potential illness
fostered competency in the women to manage an illness. The
client was, more than likely, her own self-care agent— "the
provider of self-care" (Orem, p. 117). Nurse practitioners
enabled women desiring health promotion and disease
prevention the ability to act as their own self-care agents.
The nurse practitioner functioned in the nursing system by
not only providing the screening and education that allowed
the woman to make informed decisions, but the practitioner
also provided some of the follow-up procedures for a
possible abnormal Pap smear result.
In summary. The Bethesda System provided a framework in
which to conceptualize the problem of ASCUS and HPV while
Orem's theory of self-care provided a theoretical framework
for the problem. The Bethesda System functioned to provide
more consistency in the interpreting and reporting of
cervical cytology results by use of terminology closely
associated with surgical diagnoses. Additionally, Orem's
theory of self-care supported women with health seeking
behaviors and integrated the role of the nurse practitioner
into the patient's mechanism for action.
Assumptions
For this study, the assumptions were the following:
1.

For the specimens utilized in this study there was

consistent cytology reporting over time and between
specimens.
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2. For the specimens utilized in this study there was
consistent tissue diagnosis over time and between specimens.
3. Women practiced activities they initiated and
performed on their own behalf in maintaining life, health,
and well-being.
Purpose of the Studv
The purpose of this study was to determine the
incidence of cervical dysplasia in women with and without
atypical squamous cells of undetermined significance
suggestive of human papillomavirus.
Statement of the Problem
Significant controversy has existed among women health
experts concerning the management of women with abnormal Pap
smears. While some experts recommend follow-up with repeat
pap smears (ACOG, 1993), others recommend immediate
colposcopy (Slawson, Bennett, & Herman, 1993). ASCUS and
ASCUS suggestive of HPV as defined by The Bethesda System
have been the focus of much controversy. Little research has
been published in the area of ASCUS and ASCUS suggestive of
HPV with significant contributions to patient management.
This study addressed the question: What is the incidence of
cervical dysplasia in women with and without cytology
suggestive of human papillomavirus? in order to contribute
to the body of knowledge in clinical management of women
with cytological findings of ASCUS and ASCUS suggestive of
HPV.
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Hypothesis
The hypothesis of this research was that there is no
difference in the incidence of cervical dysplasia in women
with and without cytology suggestive of human
papillomavirus.
Definition of Terms
For the purpose of this study, the following terms were
defined:
Cervical Dvsplasia
Theoretical. Cervical dysplasia as defined by The
Bethesda System is an abnormal differentiation in
proliferating cells which results in an abnormal degree of
variation in size, shape, and appearance of cells and a
disturbance in the usual arrangement of such cells (Abrams,
1992) .
Operational. Cervical dysplasia was considered to be
any level of cervical dysplasia identified by surgical
tissue (biopsy) diagnosis.
Women
Theoretical. Women are defined theoretically as female
persons.
Operational. Women were those female persons with
abnormal cervical cytology.
Cytology
Theoretical. Cytology is defined as microscopic
examination of cells desquamated by means of aspiration.
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washing, smear, etc. from a body surface in order to detect
malignancy and microbiologie changes in accordance with The
Bethesda System (Friel, 1981).
Operational.

Papanicolaou smear reports of atypical

squamous cells of undetermined significance were the
functional definition of cytology.
Atypical Sauamous Cells of Undetermined Significance (ASCUS)
Theoretical. According to The Bethesda System, cells
with abnormalities that are greater than those attributable
to reactive changes but are quantitatively or qualitatively
less than those abnormalities of a squamous intraepithélial
lesion (Kurman & Solomon, 1994).
Operational. Cytology reported on a Pap smear result
according to The Bethesda System guidelines served as the
operational definition of ASCUS.
Atypical Sguamous Cells of Undetermined Significance (ASCUS)
Suggestive of Human Papillomavirus (HPV)
Theoretical. ASCUS with other abnormal cells that give
the impression that HPV may be present but are not
identified as a definitive squamous intraepithélial lesion
according to The Bethesda System.
Operational. For this study, ASCUS suggestive of HPV
was the cytology result reported on Pap smears according to
The Bethesda System.
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Summary
Controversies have existed in the area of cervical
cytology. The Bethesda System was established to provide
continuity and clarification of cervical cytology. The
Bethesda System's classification of atypical squamous cells
of undetermined significance fell under much scrutiny.

No

consistency was found in determining the biological
significance of atypical squamous cells nor was there any
consensus in the management of women with ASCUS or of women
with ASCUS suggestive of human papillomavirus.
Orem's theory of self-care directed the role of nurse
practitioners as supportive and educative systems in
enabling women who desired health promotion and disease
prevention to act as their own self-care agents. While Orem
was utilized as the theoretical framework for this study.
The Bethesda System was established as the physiologic
framework. The Bethesda System aided the conceptualization
of the problem of ASCUS and ASCUS suggestive of HPV. The
Bethesda System provided consistency in reporting Pap smear
results and in the criteria for diagnostic interpretation.

Chapter II

Review of the Literature
An exhaustive search of the literature revealed a lack
of current research reports on cervical cytology diagnosis
of ASCUS and ASCUS suggestive of HPV. Only two recent
studies, one from 1993 and one from 1994, specifically
addressed the ASCUS designation from The Bethesda System.
Both studies were Harrisburg, Pennsylvania area network
(HARNET) studies.
The 1993 study was titled "Follow-up Papanicolaou Smear
for Cervical Atypia: Are We Missing Significant Disease?"
(Slawson, Bennett, & Herman). The purpose of the research
outlined in this study was to examine two objectives:
(1) the prevalence of undetected CIN [cervical
intraepithélial neoplasia] among women in primary
care settings with a Pap smear showing atypia of
undetermined significance, and (2) the accuracy of
a single follow-up Pap smear performed with an
endocervical Cytobrush and a wooden spatula in
identifying those women subsequently found to have
biopsy-proven CIN (Slawson et al., p. 290).
The researchers surmised that the data on which many
investigators based their recommendations for colposcopy may
have been misleading due to the referral population of women
with identified risk factors, the method by which the Pap
smears were obtained, and the adaptation of the results to
The Bethesda System for cytological analysis. Consequently,
14
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the authors stated that the risk in women with cervical
atypia and no evidence of HPV or dysplasia, which was
classified as squamous atypia of undetermined significance,
was uncertain (Slawson et al., 1993).
The design included a population of 7,458 women (N =
7,458) that presented for an initial Pap smear in one of six
family practice offices in the Harrisburg, Pennsylvania
area. Major population differences between the sites were
not identified. Each Pap smear was obtained using a
Cytobrush and wooden spatula. All abnormal Pap smears
identified by a cytotechnologist were reviewed by a board
certified pathologist that had no knowledge of the study.
Atypia of undetermined significance was identified in 442
patients and 159 remained eligible for continuation in the
study (n = 159). Out of this sample, 37 chose immediate
colposcopy while 121 women consented to wait four to six
months before returning for a repeat Pap smear and
colposcopy.

Colposcopic directed biopsies were performed by

trained and certified practitioners and were reviewed by
board certified pathologists (Slawson et al., 1993).
The prevalence rate of CIN determined by colposcopic
directed biopsies among women whose screening Pap smears
showed atypical cells of undetermined significance was 35%.
Single follow-up Pap smears had a false negative rate of
57%. One third of the high grade lesions were not identified
by Pap smears (Slawson et al., 1993).
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Of the women (n = 37) choosing immediate colposcopy, 15
(40%) were identified as having CIN I and none with a more
severe lesion. Those that waited (n = 121) had a 34%
incidence of CIN and more significantly a 12% incidence of
CIN II/III. These results may have indicated that
progression of cervical disease occurred during the four to
six month waiting period or that normal reparative healing
was not allowed to occur in the sample that underwent
immediate colposcopy (Slawson et al., 1993).
Based on data analysis, Slawson et al. (1993)
recommended that all women with cervical atypia of
undetermined significance undergo colposcopic examination.
Repeat Pap smears were encouraged every four to six months
for one to two years if initial colposcopic studies were
refused. If any abnormal cytology occurred during follow-up,
colposcopy was recommended.
One-third of the women in this study with cervical
atypia on an initial Pap smear had CIN after cervical
biopsy. The Pap smear obtained failed to detect one—half of
the cases of biopsy-proven CIN. Slawson et al.

(1993)

recommended further studies regarding the use of
supplementary screening methods. In comparison with The
Bethesda System, CIN corresponded to low grade and high
grade squamous intraepithélial lesions. These results
indicated a need for further study and the current study
pursued the meaning of ASCUS in another setting.
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Slawson, Bennett, Simon, and Herman (1994) published
another study titled "Should All Women With Cervical Atypia
Be Referred for Colposcopy: A HARNET Study. The purpose of
the research was to determine the optimal management of
women whose Papanicolaou (Pap) smears showed atypical
squamous cells of undetermined significance (ASCUS). In the
previous HARNET study, it was concluded that a Pap smear
follow-up four to six months later failed to accurately
predict abnormal colposcopic biopsies. Therefore, additional
tests to augment the follow-up Pap smear were evaluated
which included a human papillomavirus (HPV) screen and a
naked eye examination after a five percent cervical acetic
acid wash (Slawson et al., 1994).
Initial Pap smears were performed on 7458 women who
attended six Harrisburg, Pennsylvania area family clinics.
The population was from urban, suburban, and semirural
areas. ASCUS was found on 442 Pap smears (N = 442).
Consenting subjects (n = 122) waited four to six months then
returned for follow-up. A repeat Pap smear was performed and
was augmented by HPV screen (ViraPap), and naked eye
examination of the cervix after a five percent acetic acid
wash before colposcopic directed biopsies and endocervical
curettage (Slawson et al., 1994).
Augmenting the follow-up Pap smear with the acetic acid
wash predicted 73% of the abnormal colposcopic biopsies. Use
of the ViraPap had no additional effect. When identifying
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all grades of cervical lesions, the negative predictive
value was low, but with respect to high grade lesions, 93%
were detected. The Pap smear alone failed to detect one
third of the high grade lesions (Slawson et al., 1994).
Findings from the second HARNET study were that (1)
among women with cervical atypia, one-third of the cases of
high-grade disease went undetected with a single follow-up
Pap smear and (2) detection increased with a follow-up Pap
smear plus an acetic acid wash. The implication presented by
the researchers for practice was that the combined use of a
Pap smear and an acetic acid wash would reliably guide
clinical management of cervical atypia. Slawson et al.
(1994) recommended further research of additional screening
methods that might improve reliability for identifying CIN
in women with cervical atypia. Randomized controlled trials
comparing cost-effectiveness and prevention of cervical
cancer were recommended. Determining the incidence of
cervical dysplasia in women with ASCUS in an area in which
collection and interpretation of Pap smears and tissue
specimens are consistent, as attempted in this current
study, may prove cost-effective with clearer indications for
follow-up recommended for cervical atypia.
Soutter, Wisdom, Brough, and Monaghan (1986) addressed
atypical Pap smears much earlier than the previous two
studies. The purpose of the research, titled "Should
Patients With Mild Atypia in a Cervical Smear Be Referred
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for Colposcopy?" (Soutter et al., 1986, p. 70) was
constructed to answer this specific question. The
researchers believed that patients who were referred for
colposcopy because of a mildly abnormal cervical smear often
were found to have a more severe lesion than had been
detected on the cervical smear (Soutter et al., 1986).
The design was a retrospective survey. The population
was identified as women who attended a colposcopy clinic at
the Regional Gynaecological Oncology Unit (RGOU), Gateshed
in Great Britain. Their initial abnormal cervical cytology
had revealed atypical but not dyskaryotic (dysplastic)
cervical cells. The cervical smear that prompted the
referral was termed the "index smear" (Soutter et al.,
p. 70) .
Two populations were identified and samples of
convenience were utilized. Group 1, referred to RGOU from
July 1, 1983, to October 30, 1983, was initially comprised
of 199 women but 10 were excluded due to pregnancy
(N = 189). Of these, 24% were referred for cervical atypia
(n = 45).

Group 2 was identified from 22,245 computerized

cytology records from RGOU for the year 1983. The sample
(n = 102) was reduced from 1,515 women with cervical atypia
(N = 1,515) due to a varied rate of follow-up, default by
some, and the burden of performing colposcopy on all.
Additionally, the sample of women (n = 102) recently had
their first abnormal Pap smears which indicated
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cervical atypia.
These women were matched for age with the year's
population of women with atypical smears, and were
chosen so that at least 6 months had elapsed since
the initial atypical smear had been reported to
allow time for follow-up data to have been
obtained. (Soutter et al., 1986, p. 71)
Instrumentation included cervical smears performed on all
women in each sample followed by colposcopically directed
biopsies of any areas of atypical epithelium. If more than
one biopsy was taken from an individual, the most severe
diagnosis was used. If a cervical conization was indicated,
the patient was referred back to her physician for surgery
(Soutter et al., 1986).
Descriptive analyses of data reported 37% to 39% of
women in the first group with cervical atypia had final
diagnoses of CIN II (moderate dysplasia) or worse. Within
the second group, 27 patients were lost to follow-up, 56 had
a normal cervical smear and did not undergo colposcopy, and
9 had another abnormal cervical smear but a histological
diagnosis was not obtained. The remaining 10 women did
undergo colposcopically directed biopsies. One was diagnosed
with CIN I, three with CIN II, and six with CIN III (Soutter
et al., 1986).
Soutter et al. (1986) concluded that women with even
mildly atypical or dyskaryotic smears were at considerable
risk of having CIN. The authors recognized that most
colposcopy clinics in Britain were unable to cope with the
increased load of colposcopies for women with only one
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atypical cervical smear. Therefore, recommendation was for
colposcopy referrals for any degree of dysplasia on a
cervical smear. Due to increased risk for CIN in patients
with cervical atypia and inability of existing clinics to
cope with the additional load, further recommendation was
for a compromise which suggested a colposcopy if two smears
taken at an interval of at least 3 months were atypical.
Finally, a confirmatory Pap smear six months after a second
negative Pap smear was deemed prudent (Soutter et al.,
1986) .
Following a review of current literature, findings
warranted a need for more aggressive follow-up. If the
findings were significant as reported, then the burden of
prema1ignant cervical disease would seem to outweigh any
facility burden. The most significant statistic seemed to be
the false negative rates of Pap smears which ranged anywhere
from 2.4% to 69%. This research attempted to determine the
incidence of cervical dysplasia in women with cytologic
findings of ASCUS and ASCUS suggestive of HPV. With the
determination of such statistics, practitioners would gain
better understanding for follow-up measures.
Information derived from Soutter et al.'s (1986) study
is relevant. Despite the age of the study, it holds the
implication that atypia may be more important or significant
than anyone was aware of then and now. Atypia must be
followed closely through current literature, experience, and
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continued research. Researchers must remain aware as
classification systems for cervical cytology reporting are
changed or updated. Studies are strengthened when research
is conducted integrating current terminology.
Schaffer and Philput (1992) addressed HPV in their
study, "Predictors of Abnormal Cervical Cytology:
Statistical Analysis of Human Papillomavirus and Cofactors".
The purpose of the research was to "develop and compare
cohort profiles for cervical-cytology smears done from 1977
to 1989 at the student health center of a large southeastern
university" (Schaffer & Philput, 1992, p. 47). Cervical
cancer was the most common cancer in women less than 35
years old. The Centers for Disease Control (CDC) recognized
a 4 60% rise in the incidence of HPV between 1966 and 1981.
The oncogenic contribution of HPV was substantiated and the
rise of HPV was felt to correlate with the dramatic rise of
cervical cancer. However, the numbers of women with HPV
without cervical cancer indicated that other cofactors along
with HPV might lead to cervical-cytology abnormalities. The
research questions were these: "Has the incidence of
abnormal cervical cytology changed over the study period?
Can factors associated with abnormal cervical-cytology be
predicted by knowledge of the risk factors implicated in the
current professional literature?" (Schaffer & Philput, p.
47). The researchers hypothesized that by identifying
statistically significant cofactors in association with HPV,
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they could then identify those individuals at greater risk
for abnormal cervical cytology (Schaffer & Philput, 1992).
Schaffer and Philput's research was a retrospective
study and utilized a sample of convenience. All patient
records at the student health center were reviewed. The
authors identified 2,919 records (n = 2,919) out of 9,057
women's records (N = 9,057) with at least one cervical
cytology report done between September 1977 and May 1989.
Those 33% met the study criterion and comprised the sample
(Schaffer & Philput, 1992).
Schaffer developed the instrument, Cyto 4400, from a
literature review on cervical cancer. The instrument
included age at first sexual intercourse, cigarette smoking,
exposure to exogenous hormones, exposure to herpes, HPV,
Gardnerella, Chlamydia, history of a previous abnormal
cervical cytology smear, as well as the dates and results of
cervical cytology, specific infections present at the time
of each smear, treatments ordered for infections, and
whether clients were referred to a specialist, and treatment
provided by the specialist (Schaffer & Philput, 1992).
A cervical cytology severity rating scale was used.
Scale validity was determined by asking experts in women's
health to rate a list of commonly used cytology terms in
order of severity. Validity was determined to be 0.99. Some
women had more than one cervical smear and so their severity
scores were added and then divided by the number of cytology
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reports. This allowed comparison between women with
different numbers of cytology reports. However, the study
was weakened when (1) inflammation and (7) carcinoma could
be averaged and (4) mild dysplasia was not indicative of the
whole picture (Schaffer & Philput, 1992).
The most prevalent infections were Gardnerella, HPV,
and Chlamydia. There was a 10.8% rate of HPV. HPV occurrence
was significantly higher in 1987 (ANOVA, F[10, 2105] = 6.36,
P = .0001)

(Schaffer & Philput, 1992).

The 2,919 participants had 6,224 cervical smears done
during the study time of which 34.9% were abnormal. Cervical
cytology by year (ANOVA, F [10, 2,077] = 17.50, p = .0001)
indicated abnormal cervical cytology and HPV infection
peaked the same year. Chi-square analysis revealed cervical
smears of women exposed to HPV had significantly more
atypias and dysplasias. Additionally, women over 3 0 years
old did not have disproportionately high cytology severity
(Schaffer & Philput, 1992).
A stepwise regression analysis used the dependent
variable and entered three independent variables. The
researchers indicated that incomplete data sets were
excluded. HPV, the year of the cervical smear, and genital
herpes infection were the independent variables. The overall
R squared was 10%. The stepwise regression analysis did not
identify a significant model to predict cervical cytology
severity (Schaffer & Philput, 1992).
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An additive effect between HPV, herpes, and smoking was
determined by ANOVA and Duncan's multiple range test. Women
with all three variables had mean Pap smear scores of 3.33.
This was consistent with squamous atypia (Schaffer &
Philput, 1992).
Over the course of the study the increases in sexually
transmitted diseases, especially HPV, coincided with the
increase of abnormal cervical cytology . The researchers
concluded that further study was needed because "concurrent
increases in HPV infection and cervical-cytology severity"
(Schaffer & Philput, 1992, p. 50) indicate an association
between the two.
The researchers felt the stepwise regression model was
disappointing although it was significant. Schaffer and
Philput (1992) indicated that if the majority of cervical
abnormalities were resultant of HPV then HPV must not have
been detected reliably through routine Pap smear screens.
Underdiagnosis was thought to be due to inadequate cervical
sampling.
In conclusion, HPV and herpes at the time of the Pap
smear were the best predictors of abnormal Pap smears. The
addition of smoking further increased the risk for abnormal
cytology. Practitioners were cautioned to be aware of
significant risk for cervical cytology severity. Falsenegative screening rates in high risk women were thought to
be reduced with more frequent cytological screening.
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Persistent inflamination of squamous koilocytotic atypias was
indicated for additional screening; colposcopy and biopsy
were felt to be justified to be certain that neoplasia did
not exist (Schaffer & Philput, 1992).
Schaffer and Philput (1992) highlighted the importance
and impact of cervical HPV infection. Their study provided a
foundation for this researcher to investigate the suggestion
of HPV infection on cytologic smears diagnosed as ASCUS and
the incidence of cervical dysplasia. In an attempt to
determine the impact of HPV, the researcher strived to
present a greater understanding of the effects of HPV and
management of cytological findings of the same.
In summary, there was a scarcity of literature
regarding the incidence of cervical dysplasia in women with
cytologic diagnosis of ASCUS with and without suggestion of
HPV. Two HARNET studies focused on cytologic findings of
cervical atypia. Slawson, Bennett, and Herman (199 3)
questioned whether or not significant cervical disease was
being missed in primary care settings with single follow-up
Pap smears for abnormal cervical cytology classified as
atypia. In 1994, Slawson, Bennett, Simon, and Herman
questioned whether all women with cervical atypia should be
referred for colposcopy. In both studies, cervical cytology
alone failed to be reliably predictive of cervical
pathology. The HARNET studies supported a much earlier study
by Soutter, Wisdom, Brough, and Monaghan (1986). The earlier
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study concluded that women with even mildly atypical
cytology results were at considerable increased risk of
having cervical dysplasia. Human papillomavirus effects were
addressed by Schaffer and Philput (1992). They concluded
that women with cytological evidence of HPV required
additional screening including colposcopy and biopsy to
ascertain the presence of dysplasia.
None of the studies reviewed addressed the specific
incidence of cervical dysplasia in women with cytologic
results of ASCUS as defined by The Bethesda System and
results of ASCUS suggestive of HPV, another The Bethesda
System classification. Similarly, all except Schaffer and
Philput addressed the significance of cytologic findings of
cervical atypia although not in the context of The Bethesda
System. Only Schaffer and Philput (1992) studied the effect
of human papillomavirus on cervical pathology. This research
has synthesized the results of these studies to provide a
basis for determining the incidence of cervical dysplasia in
women with and without ASCUS suggestive of HPV.

Chapter III
The Method
This retrospective study, "Incidence of Cervical
Dysplasia in Women With and Without Cytology Suggestive of
Human Papillomavirus", was conceptualized to address the
problem of an undetermined significance of cervical atypical
squamous cells and an undetermined significance of cervical
atypical squamous cells suggestive of HPV. A chart audit was
conducted of medical records obtained from an OB/GYN
practice. Medical records were selected for audit by an
examination of pathology reports obtained from a local
pathology laboratory utilized by the OB/GYN practice.
Sampling design was one of convenience. Data were recorded
and quantitative analysis performed.
Variables
The independent variable was cervical cytology reports
suggestive of HPV. The dependent variable was cervical
dysplasia as determined by histologic diagnosis. Control
variables included the consistency of the clinicians in
obtaining specimens of both a cytologic and histologic
nature and the consistency of the same cytotechnologists and
pathologists interpreting specimens. Intervening variables
that may have affected the research included the length of
28
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time between collection of a specimen and when the specimen
was fixed, knowledge obtained and utilized in collection or
diagnosis of specimens, change in equipment utilized for
collection or diagnosis of specimens, misdiagnosis,
incorrect recording

of results, and client

age at first intercourse, number of

sexual

variables suchas
partners, current

sexual activity or preferences, last menstrual period, birth
control method, smoking, elapsed time before follow-up or
biopsy, presence of

other diagnosed and/or

undiagnosed

cervical or vaginal

infections, and age at

time of ASCUS

diagnosis.
Setting. Population, and Sample
The setting for this research was a college town in the
southeastern United States. The town was located in a rural
area approximately 70 miles from a large metropolitan
center. The population of the town combined with the
population of the campus included approximately 10,000
females. The area medically served was approximately 49%
Caucasian and 49% African-American. The college was
approximately 10% African-American and approximately 85%
Caucasian. Foreign students comprise about 5% of the college
population. Approximately 40% of the college students were
classified as out of state; 60% were classified as residents
(Board of Trustees of State Institutions of Higher Learning,
1994) .
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For the purpose of this study, the population (N = 442)
included cervical cytology reports of women whose Pap smears
were reported as ASCUS or ASCUS suggestive of HPV from March
1994 through May 1995. The sample (N = 58) included all
medical records of women presenting to one obstetric and
gynecologic (OB/GYN) practice for follow-up of cytology
indicating ASCUS or ASCUS suggestive of HPV that culminated
in colposcopically directed cervical biopsies. Two board
certified obstetrician/gynecologists (OB/GYNs) performed
biopsies. The Pap smears and biopsies were diagnosed by one
pathology group which was comprised of two board certified
pathologists and two certified cytotechnologists.
The first cytology report of ASCUS or ASCUS suggestive
of HPV was termed the index smear. Two sample subsets were
established based the reported presence of HPV on the index
smear report. The first sample subset consisted of cytology
reports of ASCUS (n = 42) while the second subset consisted
of cytology reports of ASCUS suggestive of HPV (n = 16).
Methods of Data Collection
Instrumentation and Procedure
Permission to conduct this study was granted by the
Internal Review Board of Mississippi University for Women
(see Appendix C) and also the pathologists and OB/GYNs of
the charts reviewed. The permission form illustrated in
Appendix D was utilized to obtain permission from the
physicians. Names of the practices were inserted before
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presenting the forms. The forms were explained to the
physicians and each signed appropriately. The forms remained
in the possession of the researcher to assure anonymity.
Names of clients with cytologic diagnosis of ASCUS were
obtained from the pathology group. The corresponding charts
in the office of the OB/GYNs were utilized to obtain results
of follow-up cervical biopsies. Demographic observations
were made of the sample utilizing the Registration Slip and
Patient Questionnaire forms which had been provided to all
patients at the OB/GYN practice and the GYN Cytology and
Pathology forms from the pathology laboratory (see
Appendixes E, F, G, and H for respective forms). Not all
information requested was given by the patient but some
consistency in information reported was noted.
Information normally reported by patient and/or
physicians that could be considered intervening variables
(Schaffer & Philput, 1992), as well as demographic
characteristics, was recorded for the purpose of sample
description. Due to the retrospective nature of this study,
accessible data consisted of race, year of birth, age at the
time of the first ASCUS or ASCUS suggestive of HPV report
and biopsy date, date of the last menstrual period preceding
the index cytology report and preceding the biopsy, smoking,
birth control methods, evidence of Candida, herpes simplex
virus, bacteria, and chlamydia, pregnancy, and the number of
previous abnormal Pap smears in the pathology laboratory
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before the biopsy. After data collection was completed, a
set of 200 random numbers was generated using the Lotus 12 3
©RAND function. These numbers were then assigned to
individual cases and names were deleted to assure anonymity
(see Appendix I for raw data).
Method of Data Analysis
Descriptive and inferential statistics were utilized
for data analysis. The incidence of cervical dysplasia in
women with ASCUS and the incidence of cervical dysplasia in
women with ASCUS suggestive of HPV were reported as
percentages of occurrences in the sample subsets. A chisquare analysis was utilized to determine statistical
significance of the incidence of cervical dysplasia in the
sample subsets at a = 0.05.
Limitations
Many limitations were encountered throughout the
research. The first limitation was the lack of current
published research evaluating ASCUS and ASCUS suggestive of
HPV. The studies that did exist did not utilize The Bethesda
System.
Along with changes in classification systems over
recent years, changes in cervical cell collection techniques
also occurred. This affected the generalization to and
comparison with previous studies. Another limitation
encountered was the potential inconsistency in adapting one
classification system to another.
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Follow-up Pap smears were not augmented with additional
screening techniques by the gynecologists in this study. The
gynecologists' normal follow-up for one Pap smear result of
ASCUS with or without suggestion of HPV was to repeat the
Pap smear in three to six months. If the patient was
pregnant and colposcopy indicated, follow-up was sometimes
delayed. If the patient was not trusted to follow-up, a
colposcopy was sometimes performed instead of a repeat Pap
smear. False negative rates of cytologic interpretation were
unknown.
The fact that the sample was one of convenience has
inherent weaknesses. Neither variables nor randomization
could be controlled. Exposure of the clinicians and clients
to increased knowledge of HPV had to be identified as a
potential limitation. With increased knowledge about and
awareness of HPV by the clinicians, bias may have also
increased. With public education, more women have identified
themselves at increased risk for HPV and present sooner and
more often for Pap smears than in previous years. The
incidence of cervical dysplasia may have appeared increased
only due to the increased presentation of those clients at
increased risk.
In summary, the quantitative research design was
introduced along with its relevance to this study.
Independent and dependent variables were stated. Many
intervening variables were outlined. Descriptions were given
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of the setting, population, and sample. Instrumentation of
data collection was presented along with the procedures for
data collection and recording. The methods of data analysis
requiring calculations of percentages and a chi-square value
were presented. Limitations were acknowledged as affecting
the outcome of the research.

Chapter IV
The Findings
The purpose of this study was to determine the
incidence of cervical dysplasia in women with and without
atypical squamous cells of undetermined significance (ASCUS)
suggestive of human papillomavirus (HPV). This retrospective
study addressed the problem of an undetermined significance
of cervical atypical squamous cells and ASCUS suggestive of
HPV. Sampling was one of convenience. Chart audits were
performed on medical records from an OB/GYN group for the
purpose of data collection and quantitative analysis.
Description of the Sample
The sample was derived from a population of Pap smear
reports of ASCUS by the pathology laboratory. From the list
of 442 Pap smear reports of ASCUS and ASCUS suggestive of
HPV (N = 442 ), 58 smears culminated in biopsies. Those Pap
smears that culminated in cervical biopsies comprised the
sample set (N = 58) and were the focus of this study.
The 58 cases in the sample set were selected on the
basis of several criteria. First, the subjects must have had
a Pap smear and/or biopsy within the time frame of the
study, March of 1994 through May of 1995. Second, an index
smear reporting ASCUS or ASCUS suggestive of HPV must have
35
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been satisfactory for evaluation according to The Bethesda
System. Two subsets, ASCUS (n = 42) and ASCUS suggestive of
HPV (n = 16), were determined by the index smear report.
Third, the index smear must have culminated in a
colposcopically directed cervical biopsy. Biopsies were
performed subsequent to one abnormal Pap smear in 62.1% of
the cases, subsequent to two abnormal smears in 36.2% of the
cases, and subsequent to three abnormal smears in 1.7% of
the cases. Subjects were eliminated if there was a cytology
report of any dysplasia preceding the index smear or if
treatment with cervical cryotherapy, conization, or laser
vaporization was noted.
One Asian, 16 African Americans, and 41 Caucasians were
identified during chart audits of the sample (N = 58). Ages
reported on index Pap smears ranged from 17 to 53 years.
Figure 1 illustrates the distribution of ages. A summary of
sample demographics is presented in Table I .
Results of Data Analvsis
The null hypothesis was that there is no difference in
the incidence of cervical dysplasia in women with and
without cytology suggestive of human papillomavirus. Both
descriptive and inferential statistics were utilized for
analysis of sample data. Descriptive results indicated an
incidence of cervical dysplasia in women with ASCUS (n = 42)
of 3 0.95%, and an incidence of cervical dysplasia in women
with ASCUS suggestive of HPV (n = 16) of 18.7 5%. This
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Table I
J L X X J O Ç XgP

f,,,,

C IX X V ^

ASCUS sucfaestive of HPV. usiner Freauencies; (f) and
Percentiles f%]

Demographic
Characteristics
Race
African-American
Asian
Caucasian

ASCUS
Suggestive of HPV
ASCUS
(n = 42)
(n = 16)
f
%
f
%

Total
(N = 58)
f
%

73.81

5
1
10

31.25
6. 25
62 .50

16
1
41

27.59
1.72
70. 69

9

21.43

7

43.75

16

27.59

20
6
0
0
3
1
9

47.62
14.29
7.14
2.38
21.43

10
1
1
1
1
0
2

62.50
6.25
6.25
6.25
6.25

30
7
1
1
4
1
11

51.72
12.07
1.72
1.72
6.90
1.72
18.97

Post-menopausal

3

7.14

0

3

5.17

Pregnant

3

7.14

0

3

5.17

Infection on cytology
Candida
Herpes Simplex Virus
Bacteria
Chlamydia

6
2
5
1

14.29
4.76
11.90
2.38

2
0
1
0

8
2
6
1

13.79
3.45
10.34
1.72

Smoker
Birth Control Method
Oral contraceptives
Tubal sterilization
Natura1/rhythm
Diaphragm
Condoms
Norplant
None/unknown

11
0
31

26.19

12.50

12.50
6.25

represents a 12.2% point difference between the two subsets
and a 65% higher incidence rate of cervical dysplasia in the
women with Pap smear reports of ASCUS without evidence of
HPV. Table II further illustrates these findings. Subjecting
data to analysis utilizing contingency table and chi-square
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statistics revealed X^(l, N = 58) = 0.8629, p <.05,
E = 0.353.
Table II

Women with ASCUS Suaaestive of HPV
Cytologic diagnosis
ASCUS

ASCUS suggestive of HPV

Cervical
dysplasia

No cervical
dysplasia

13

29

42

30.95%

69.05%

100%

13

16

81.25%

100%

3
18.75%

(n)
Total

Using subsets of cytology reports of ASCUS (n = 42)
and ASCUS suggestive of HPV (n = 16) and the frequency of
dysplasia and no dysplasia on biopsy, a chi-square value
with one degree of freedom was derived. The chi-square value
obtained was 0.8629. This represents a probability value of
0.353 or approximately a 35% chance that a distribution of
observations exists that would be more likely to show a
dependency, or relationship, between cytological diagnosis
of HPV and biopsy proven cervical dysplasia. Therefore,
using the chi-square results, the null hypothesis cannot be
rejected at a level of a = .05. Table III further
illustrates these results.
Additional Findings
Many additional findings surfaced during collection and
analysis of the data from chart audits. Of the biopsies
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Table III

Contingency Table and Chi-Sauare Results for Cervical
Dvsplasia bv HPV on Cvtologv
No HPV

HPV

Total

No Dysplasia

Frequency
Total Percent
Row Percent
Column Percent

29
50.00
69.05
69.05

13
22.41
30.95
81.25

42
72.41

Dysplasia

Frequency
Total Percent
Row Percent
Column Percent

13
22.41
81.25
30.95

3
5.17
18.75
18.75

16
27.59

Total

Frequency
Percentage

42
72.41

16
27.59

58
100.00

Note. Chi-Square Value with 1 df = 0.864, p = 0.353.
Chi-Square rejection value with 1 df at a = 0.05 is 3.71.
(N = 58), 74.14% or 43 biopsies confirmed dysplasia and/or
HPV. Dysplasia was recorded on 16, or 27.59%, of the
pathology reports, and of these 16 reports, 14 also recorded
HPV. HPV without dysplasia was recorded in 28 cases or
48.27% of the pathology reports. A total of 42 pathology
reports indicated HPV (72.4%).
While 16 index smears had cytology consistent with
ASCUS suggestive of HPV, only 11 of them confirmed HPV by
biopsy. No pathological diagnosis of HPV was given on five
reports. Mild dysplasia was diagnosed in three of these 16
biopsies; of these three, two were also diagnosed with HPV.
Only one of these observations indicated no HPV on cytology
yet diagnosed dysplasia on biopsy.
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HPV was not noted in 42 of the index cytology reports.
In this subset (n = 42), HPV was diagnosed by biopsy in 31
of those observations while 13 reports of dysplasia were
noted. There was only one observation in which dysplasia was
diagnosed without HPV. Biopsies revealed 19 observations of
HPV without dysplasia. Twelve of the 42 reports of ASCUS
without evidence of HPV culminated in biopsies with
diagnoses of both dysplasia and HPV.
Out of the 58 biopsy reports, three revealed high grade
dysplasia— approximately 5% of the total sample. Chart
audits of these three revealed all to be Caucasian and oral
contraceptive users 21, 28, and 30 years of age. Two were
smokers, and none had index cytology suggestive of HPV. All
histopathology indicated HPV along with high grade
dysplasia. Elapsed times between the index smear and biopsy
were 175 days, 187 days, and 229 days. The mean elapsed time
was 197 days for these three observations.
Elapsed time (Schaffer & Philput, 1992; ACOG, 1993)
from date of index smear to date of biopsy ranged from 0—
that is, the biopsy was done immediately following the index
Pap smear, to 517 days. The mean elapsed time from the date
of the index Pap smear to the biopsy date was 143.67 days
for the sample (N = 58). Pap smears reporting ASCUS (n = 42)
had a mean elapsed time of 148.2 days prior to biopsy.
Reports of ASCUS suggestive of HPV (n = 16) had a mean
elapsed time of 131.7 days prior to biopsy. The mean elapsed
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time was 140.7 days for smears that culminated in biopsy
proven dysplasia and 144.5 days for cytology that culminated
in HPV. Four of the observations that culminated in biopsies
identifying cervical dysplasia had elapsed times of 35 days
or less.
Chart audits also revealed four clients used condoms
for birth control. Of those four, all had pathology reports
of HPV. Three of the pathology reports also diagnosed mild
dysplasia.
Eight index Pap smears revealed Candida. Two of these
also suggested HPV while only one of the two had a HPV
diagnosis from biopsy. HPV was diagnosed from biopsies of
three of the index smears that revealed Candida without HPV.
Only one index Pap smear that reported Candida culminated in
a biopsy with dysplasia without HPV while the cytology
report also gave no evidence of HPV.
Summarv
In summary, the null hypothesis, there is no difference
in the incidence of cervical dysplasia in women with and
without cytology suggestive of HPV, failed to be rejected
based on inferential analysis with a chi-square value,
X^(l, N = 58) = 0.8629, p <.05, p = 0.353. However,
descriptive statistics revealed an increase of 65% in the
incidence of cervical dysplasia in cases of women without
evidence of HPV as reported on the index Pap smear over
cases with evidence of HPV as noted on the index cytology
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report. The descriptive statistics along with the chi-square
analysis does seem to indicate a relationship although weak
and statistically non-significant.

Additional findings from

chart audits have been presented. The findings reveal
information regarding the pathological diagnosis of HPV and
dysplasia.

Chapter V
The Outcomes
Notable controversy has existed in the areas of
management of women with a cytological diagnosis of atypical
squamous cells of undetermined significance (ASCUS) and
women with the diagnosis of ASCUS suggestive of human
papillomavirus (HPV). Due to frequent changes in cytology
reporting, inconsistencies between reportings, and lack of
current literature, further investigation into the areas of
cervical cytology reportings of ASCUS and ASCUS suggestive
of HPV was deemed necessary. A null hypothesis, there is no
difference in the incidence of cervical dysplasia in women
with and without cytology suggestive of HPV, was proposed.
The purpose of this retrospective study was to determine the
incidence of cervical dysplasia in women with ASCUS and in
women with ASCUS suggestive of HPV in order to provide
improved and appropriate management to both groups of women.
This chapter presents a summary of the significant findings,
additional findings, discussion, review of the physiological
conceptual framework, conclusions, implications for nursing,
and recommendations for further study.
A chart audit was conducted of medical records from an
OB/GYN medical practice. Observations were made of medical
records containing Pap smears with the diagnosis of ASCUS
44
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and ASCUS suggestive of HPV that had culminated in cervical
biopsies. The setting was an area of the southeastern United
States. The population (N = 442) included medical records of
women with cytologic diagnosis of ASCUS and ASCUS suggestive
of HPV made by a pathology group utilized by the OB/GYN
group for cervical screening and diagnosis. Descriptive and
inferential statistics were utilized for data analysis.
The null hypothesis, there is no difference in the
incidence of cervical dysplasia in women with and without
cytology suggestive of HPV, failed to be rejected based on
chi-square analysis at a = 0.05. Descriptive statistics did,
however, indicate a 65% greater incidence of HPV in women
with cytology reports of ASCUS than in women with cytology
reports of ASCUS suggestive of HPV. The descriptive
statistics do highlight a possible relationship but the chisquare analysis indicates a weak, statistically non
significant relationship at best. Additional findings
revealed information pertaining to the histological
diagnosis of HPV and dysplasia.
Summarv of Findings
The sample, N = 58, was comprised of Pap smear reports
of ASCUS (n = 42) and ASCUS suggestive of HPV (n — 16) that
culminated in cervical biopsies. An array of demographic
factors was identified through chart audits.
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Significant Findings
The incidence of cervical dysplasia was found to be
greater in women with cytology reporting ASCUS than in women
with cytology reporting ASCUS suggestive of HPV. The
incidence of cervical dysplasia in women with ASCUS (n = 42)
was 30.95% while the incidence of cervical dysplasia in
women with ASCUS suggestive of HPV (n = 16) was 18.75%.
These findings represent a 65% increase in the incidence of
biopsy proven cervical dysplasia after index Pap smears of
ASCUS over the incidence of cervical dysplasia after index
Pap smears of ASCUS suggestive of HPV. Inferential analysis
utilizing contingency tables and a chi-square value
indicated a statistically non-significant relationship
between the incidences of cervical dysplasia in the two
subsets, X^(l, n = 58) = 0.8629, p < .05, p = 0.353.
Therefore, the researcher failed to reject the null
hypothesis at a = 0.05.
Additional Findings
While 74.14% of the cervical biopsies (N = 58)
confirmed HPV and/or dysplasia, HPV was found to have a
higher incidence of occurrence than dysplasia. A total of 42
pathology reports, 72.4%, diagnosed HPV while a diagnosis of
dysplasia was reported in only 27.59% of the sample. Of the
subset reporting ASCUS (n = 42), 30.95% had biopsy proven
dysplasia; of the subset reporting ASCUS suggestive of HPV
(n == 16), 18.75% had biopsy proven dysplasia.
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Approximately 5% of the cases in the sample (N = 58)
diagnosed high grade dysplasia. All three cases revealed
Caucasian race and oral contraceptive users. None had
evidence of HPV on cytology but HPV was confirmed along with
the high grade dysplasia in each of the biopsies.
All clients reporting condom use for birth control were
found to have HPV on biopsy. Mild dysplasia was also
reported in 75% of those cases of HPV in condom users.
Further findings resulted from additional examination
of demographic variables. Of the 58 cases in the sample set,
70.69% of the women were reported to be Caucasian while
27.59% were African Americans and 1.7% were Asian. The
sample revealed a positively skewed bimodal distribution of
ages. Ages ranged from 17 years to 53 years at the time of
the index Pap smear. The mean sample age was 29.6 years. The
mean age for the subset of reports demonstrating ASCUS was
29.29 years and for the subset demonstrating ASCUS
suggestive of HPV was 30.56 years. Smoking was reported in
2 7.6% of the sample. Chart audits revealed 51.7% of the
sample reported use of oral contraceptives for birth
control.
Discussion
The researcher failed to reject the null hypothesis,
there is no difference in the incidence of cervical
dysplasia in women with and without cytology suggestive of
HPV. Although inferential statistical analysis using chi-
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square found no significant relationship in differences of
incidences of cervical dysplasia, descriptive statistics did
seem to indicate a relationship between cytology suggestive
of HPV and biopsy proven dysplasia. However, the inferential
analysis reveals this relationship to be weak and not
statistically significant.
Utilizing descriptive statistics, a greater incidence
of biopsy proven dysplasia with ASCUS than with ASCUS
suggestive of HPV is noticeable. In part, this may appear so
because there exists a morphologic overlap in cytology.
Subjective variations between cytotechnologists and
pathologists exist thus creating diagnostic dilemmas. The
assumption was made, however, that within the pathology
laboratory utilized, there would be consistency in reporting
over time and between specimens. Some confusion does
continue to exist in pathology in classifying ASCUS and HPV
on cytologic smears. The need is thus demonstrated that
ASCUS with or without evidence of HPV must be followed
closely.
Paps reflecting ASCUS diagnoses culminated in many
biopsy proven cases of HPV when no evidence of HPV was seen
on the Pap smear, 31 out of 42. Again, this may be due to
the morphologic overlap in pathology reporting. Perhaps some
criteria was met for HPV classification on cytology but not
all criteria was met. Results may be skewed, however, due to
the large number of assumed sexually active college women
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having more than one partner. The local college has
demonstrated a higher than national average in the diagnosis
of HPV on cytology. Conversely, HPV suggested by Pap smear
but not identified by biopsy, causes some concern. This
inconsistency may be due in part to biopsy sampling error or
overdiagnosis by the pathology laboratory. However, it is
most likely due to reactive or inflammatory changes of cells
collected for cytologic evaluation.
Some concern has existed as to whether or not the
presence of Candida interferes with the ability to make an
accurate cytologic diagnosis as Candida may mimic changes
seen with ASCUS and thus lend to some overcall of ASCUS.
Interference by Candida is not obvious from this data. The
pathology laboratory utilized has not been steered to
wrongful diagnoses in the presence of Candida.
Condom users in this study demonstrated a 100% biopsy
proven HPV rate. One must take into consideration whether or
not condoms were used consistently, and if HPV was present
before condoms were utilized. Assuming 100% compliance,
inference can be made that condoms are hardly protective of
HPV transmission.
Interest and concern surface as a result of the
diagnoses of high grade dysplasia in 5% of the sample.
Enough atypia was identified on the Pap smear that the cases
were not lost. This, however, represents a broad spectrum of
pathology that can be high grade but sampling on a Pap smear
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can lead to errors in diagnoses. Sampling errors may be the
result of the size of the abnormal lesion— if the lesion is
minuscule, there would be a decreased chance of obtaining
those cells. The location of the lesion may not be easily
accessible and thus may not be reached with the Cytobrush or
Ayre wooden spatula, especially if the lesion lies within
the glands of the cervix.
After biopsies, 74.14% of the sample (N = 58), ASCUS
and ASCUS suggestive of HPV, demonstrated confirmed cervical
dysplasia and/or HPV. This appears to represent a strong
relationship between cytologic atypia and histologic atypia.
Problems with the design of the study may have affected
the results. It was hoped that the use of one OB/GYN group
and one pathology laboratory would strengthen the study.
Inherent, however, is the acknowledgement that this may also
be a theoretical shortcoming of the design. Two different
doctors performed colposcopies, and biopsy specimens were
interpreted by two different pathologists. Pap smears were
interpreted by two cytotechnologists and two pathologists.
This does not appear to be a fatal flaw, but it may account
for some of the subjective variations in classifications.
Another inherent limitation was the sample size and time
frame of the study. While specific guidelines for management
are not established, the time frame limits the inferences
that can be drawn with respect to management. The time frame
of this study did, however, allow for consistency in

51

cytological classifications utilizing The Bethesda System.
There will be questions as to whether or not a larger sample
or a longer time frame would have significantly altered
results in either the descriptive or inferential analyses.
Also, extension of the results of this study to the general
population may be difficult as the sample population may not
adequately reflect the populations in other geographic
areas.
Findings of this study lend support to most but not all
of the current published literature. Kurman and Solomon
(1994) indicated ASCUS results reflected either an exuberant
benign change or a potentially serious lesion, and,
therefore, were interpreted to be of undetermined
significance. The sample utilized in this study, N = 58,
revealed biopsy proven HPV and/or dysplasia in 74.14% of the
cases. Only 25.86% of the biopsies were benign. These
results strengthen the case for ASCUS findings representing
potentially serious lesions.
Slawson et al. (1993) reported a 35% prevalence rate of
biopsy proven CIN among women whose screening Pap smears
showed ASCUS while this study revealed a prevalence rate of
dysplasia in a subset of women whose index Pap smears showed
ASCUS (n = 42) of 30.95% and in the total sample (N = 58) of
27.59%. However, 74.14% of this total sample had an
occurrence of biopsy proven dysplasia and/or HPV.
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Slawson et al. (199 3) also reported results that may
indicate progression of cervical disease occurred during the
four to six month waiting period after an initial ASCUS.
Results of this study revealed a mean elapsed time from the
index Pap smear to biopsy of 143.67 days or approximately 5
months in which, again, a rate of 74.14% of biopsy proven
dysplasia and/or HPV was identified. While Slawson et al.
reported that the Pap smear alone failed to detect one third
of the high grade lesions, this study demonstrated that none
of the high grade lesions with HPV on biopsy were predicted
by Pap smears and were classified as ASCUS (with no evidence
of HPV). Thus, this study supports Slawson et al. in both
the prevalence rate and the elapsed time measures. This
research was even more definitive in recognizing that Pap
smears alone may fail to detect the presence of high grade
lesions.
Soutter et al. (1986) concluded that women with even
mildly atypical or dyskaryotic smears were at considerable
risk of having CIN. Despite the date of the study, the
implication that atypia may be more important or significant
than realized is supported by this current study. Their
conclusions will continue to be strengthened with
replications studies in which current terminology is
integrated.
Schaffer and Philput (1992) found a significant chisquare relationship between exposure to HPV and cervical
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atypias and dysplasias on cytology. However, this research,
while not testing for atypias, found a high percentage of
biopsy proven HPV in women with ASCUS. While Schaffer and
Philput concluded that women with cytological evidence of
HPV required additional screening to ascertain the presence
of dysplasia, the prevalence of dysplasia in this study was
greater in the subset of reports of ASCUS than in the subset
of reports of ASCUS suggestive of HPV.
The Bethesda System was utilized exclusively by the
pathology laboratory in reporting cervical cytology during
the time frame of this study. This consistency in
classification and use of terminology closely related to
histopathologic vocabulary strengthened this study.
Knowledge of specimen adequacy as satisfactory was utilized
as part of the criteria for inclusion in this study as was
the cytological classifications of The Bethesda System.
Orem's theory of self-care provided the basis for the
assumption that women practice activities they initiate and
perform on their own behalf in maintaining life, health, and
well-being. With additional knowledge gained from this
study, nurse practitioners will be able to function in the
educative-supportive role in the nursing system to foster
health and well-being through disease prevention and health
promotion related to cervical cancer screening. With
detection of abnormal cervical cytology, nurse practitioners
will have additional knowledge to support the educative
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efforts in promoting women's understanding of the risks
associated with any abnormal Pap smear.
Conclusions
Scarcity of current published research on the dilemma
of diagnosis and management of women with ASCUS and ASCUS
suggestive of HPV prompted this study. A null hypothesis was
proposed: There is no difference in the incidence of
cervical dysplasia in women with and without cytology
suggestive of HPV. Descriptive statistics and inferential
analysis suggested a weak statistically non-significant
relationship between cytologic diagnosis of HPV and biopsy
proven dysplasia. Thus, the researcher, using chi-square
analysis at a rejection level of a = 0.05, failed to reject
the null hypothesis. Findings indicate the need for further
research and closer monitoring of patients with cytologic
diagnosis of cervical ASCUS with or without suggestion of
HPV.
While no previous studies have addressed this specific
problem, some studies do parallel this research in examining
cervical cytology reports and/or histopathology reports
(Slawson et al., 1993; Slawson et al., 1994; Soutter et al.,
1986; Schaffer & Philput, 1992). The identified prevalence
rate of dysplasia on cervical biopsy reports of 30.95%
supports findings reported by Slawson et al.

(1993). Elapsed

time between the Pap smear and progression of cervical
disease from ASCUS or ASCUS suggestive of HPV of

55

approximately five months also lends support to Slawson et
al.'s study. Five percent of seemingly mild Pap smear
abnormalities resulted in diagnoses of high grade dysplasia
on biopsy. This is consistent with the findings of Slawson
et al. reported in 1994 and also with findings reported by
Soutter et al. in 1986. The greater prevalence of HPV
identified on cervical biopsy than on cervical cytology
found in this research supports findings reported by
Schaffer and Philput (1992).
While support is given to previous studies, some
different findings also exist. The most significant
difference, however, is the chi-square value obtained in
this research. Analysis identified a non-significant
relationship between the incidences of dysplasia in women
with index Pap smear reports of ASCUS and ASCUS suggestive
of HPV. Schaffer and Philput (1992) utilized chi-square
statistics and determined that women exposed to HPV had
significantly more atypias and dysplasias.
Implications for Nursing
The body of nursing knowledge has increased as a result
of this study and the areas of research, theory, practice,
and education have been strengthened. Validation of the
importance of ASCUS and ASCUS suggestive of HPV through
research helps to identify nursing actions that are within
the realm of nursing practice and helps delineate the unique
role of nursing in health care today. When findings from
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studies are similar, nurses will have a greater impact on
patient outcomes. As suggested in this study, ASCUS and
ASCUS suggestive of HPV have a much higher incidence of
pathological changes on cervical biopsy than is indicated by
Pap smears. Through understanding of the pathology of ASCUS
and ASCUS suggestive of HPV, risk factors, screening,
diagnosis and treatment, nurse practitioners can interrupt
the spread of HPV, decrease pathogenic consequences of both
ASCUS and HPV, and thus, avoid greater consequential
outcomes as in the reduction of the incidence of cervical
cancer. Nurse practitioners will also have the opportunity
to evaluate progression or regression of cervical ASCUS and
ASCUS suggestive of HPV. The educative effort of the nurse
practitioner follows Orem's nursing system as does the
intervention. If HPV is detected, counseling the infected
woman on transmission, treatment, and prevention of
reinfection is a large educative effort.
Nurse practitioners today are involved not only in
counseling, education, and cervical cytology screening for
women, but many have assumed a greater role to include
performing colposcopies along with colposcopic directed
biopsies. Nurse practitioners must demonstrate proficiency
in this area in order to assure acceptance and respect by
members of the health care profession and the communities in
which they serve.
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Nurse practitioners have the responsibility to identify
needs of the profession. They must remain abreast of current
research, treatment, technology and educational issues. All
four areas must be integrated into nurse practitioner
curriculums to effectively prepare students for the role of
primary care providers. Practitioners must remain aware of
changes or updates in the classification systems for
cervical diagnosis through networking and continued
education.
Not only will the client and the nurse practitioner
benefit from this study, but other health disciplines will
also benefit as they acknowledge the integral role that
nurse practitioners and nursing research play in today's
health care.
Recommendations for Further Studv
Recommendations for further study have been derived
from lack of current published research on the importance of
ASCUS and ASCUS suggestive of HPV. Questions have surfaced
related to a lack of complete information and to time
restraints. Continued research in this area will improve the
scientific base for not only nursing practice but also the
practice of other health professionals. Recommendations for
further study are the following:
1.

Follow-up longitudinal study on the incidence of

cervical dysplasia in women with cytology reportings of
ASCUS and ASCUS suggestive of HPV.
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2. Follow-up study on the incidence of cervical
dysplasia in women with cytology reportings of ASCUS and
ASCUS suggestive of HPV in other settings with different
populations.
3. Follow-up study on the incidence of cervical
dysplasia in women with cytology reportings of ASCUS and
ASCUS suggestive of HPV with cytology sampling and cervical
biopsies done by others and evaluation of cytology and
histopathology by others.
4. Identification of HPV strains in this area and their
relationship to cervical smears and biopsies.
5.

Identification of demographic variables of groups

of

ASCUS and groups of ASCUS suggestive of HPV and their
relationships.
6. Identification of significance of numbers of reports
of ASCUS or ASCUS suggestive of HPV prior to biopsy and
cervical diagnostic severity.
7.
between

Identification of significance of elapsed time
index smear of

ASCUS and ASCUS suggestive of HPVand

the incidence of biopsy proven cervical dysplasia and/or
HPV.
8. Correlation of cervical cytology diagnoses and
histopathologic diagnoses with Pap smears and colposcopic
directed biopsies performed by nurse practitioners.
9. Establishment and implementation of a colposcopy
training program for nurse practitioners.
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10. Acceptance of nurse practitioners as primary care
providers in women's health in Mississippi.
11. Development of a program for recording pertinent
data that may be linked to Pap smear results and biopsies in
order for relationships to be established.
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Appendix A
The 1991 Bethesda System

The 1991 Bethesda System
Adequacy of the specimen
Satisfactory for evaluation
Satisfactory for evaluation but limited by
(specify reason)
Unsatisfactory for evaluation (specify reason)
General categorization (optional)
Within normal limits
Benign cellular changes : See descriptive diagnoses
Epithelial cell abnormalities: See descriptive
diagnoses
Descriptive Diagnoses
Benign cellular changes
Infection
Trichomonas vaginalis
Fungal organisms morphologically consistent
with Candida species
Predominance of coccobacilla consistent with
shift in vaginal flora
Bacteria morphologically consistent with
Actinomyces species
Cellular changes associated with herpes simplex
virus
Other
Reactive Changes
Reactive cellular
Inflammation
Atrophy with
Radiation
Intrauterine

changes associated with
(includes typical response)
inflammation ("atrophic vaginitis")
contraceptive device; Other

Epithelial Cell Abnormalities
Squamous cell
Atypical squamous cells of undetermined
significance : Quality^
Low-grade squamous intraepithélial lesion
encompassing HPV^; mild dysplasia/CIN 1
High-grade squamous intraepithélial lesion
encompassing moderate and severe dysplasia,
CIS/CIN 2, CIN 3
Squamous cell carcinoma
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Glandular Cell
Endometrial cells, cytologically benign, in a
post-menopausal woman
Atypical glandular cells of undetermined
significance: Quality^
Endocervical adenocarcinoma
Endometrial adenocarcinoma
Extrauterine adenocarcinoma
Adenocarcinoma, NOS
Other Malignant Neoplasms: Specify
Hormonal Evaluation (applies to vaginal smears only)
Hormonal pattern compatible with age and history
Hormonal pattern incompatible with age and history:
Specify
Hormonal evaluation not possible due to: Specify
* HPV indicates human papillomavirus; GIN, cervical
intraepithélial neoplasia; CIS, carcinoma in situ; and NOS,
non-organ specific.
^ Atypical squamous or glandular cell of undetermined
significance should be further qualified, if possible, as to
whether a reactive or a premalignant/malignant process is
favored.
^ Cellular changes of HPV previously termed koilicytosis,
koilocytotic atypia, or condylomatous atypia are included in
the category of low-grade squamous intraepithélial lesion.
Source. The Bethesda System Committee, The Bethesda System
for Reporting Cervical/Vaginal Cytologic Diagnoses. American
Journal of Surgical Patholocrv. 16,(9). 1992.

Appendix B
Comparisons of Cytology Classifications

Comparisons of Cytology Classifications
Class

Traditional

Cervical
Intraepithélial
Neoplasia (CIN)

Bethesda
System

I

Negative

n/a

Within normal
limits

I

Negative
(Inflammation
Trich, Candida,
Bacteria)

n/a

Within normal
limits

II

Atypical cells
Reactive atypia
Atypical Repair

n/a

Other - Reactive
Atypia- atypical
Repair- atypical
Metaplasia

II

Atypical cells
(Cannot exclude
dysplasia)

n/a

III

HPV (Flat
condyloma)

ASCUS - AGCÜS*
Herpes- atypical
Metaplasia of
undetermined
significance
Low arade
Squamous
Intraepithélial
Lesion

III

Mild dysplasia

CIN 1 with or
without HPV

III

Moderate
dysplasia

CIN 2 with or
without HPV

Hiah arade
Squamous
Intraepithélial
Lesion

IV

Severe

IV

Carcinoma in-situ

v

Squamous
carcinoma

CIN 3 with or
without HPV
Squamous
carcinoma

Glandular atypia - Class II or III
Source. Adapted from Valente and Schantz, April 1993.
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Appendix C
Mississippi University for Women
Committee on Human Subjects in Experimentation
Letter of Approval

M ississippi
U n iv e r s it y

Vice President for Academic Affairs
P.O. Box W-1603
(601) 329-7142

FORW O M E N
Columbus, MS 39701

February 22, 1995

Ms. Deanna Mackie
c/o Graduate Nursing Program
Campus
Dear Ms. Mackie:
I am pleased to inform you that the members of the Committee
on Human Subjects in Experimentation have approved your proposed
research with the requirement that permission to conduct the survey
and to review the records be obtained from any clinics and/or
M.D.'s in advance.
I wish you much success in your research.
Sincerely,,

Tlfomas C. Richardson
Vice President
for Academic Affairs
TR:wr
cc:

Mr. Jim Davidson
Dr. Mary Pat Curtis
Dr. Rent

Where Excellence is a Tradition
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Appendix D
Memorandum of Agreement Concerning Research Study

Memorandum of Agreement Concerning
Research Study

Title of Study:
Incidence of Cervical Dysplasia in Women With and
Without Cytology Suggestive of HPV
Name of Practice:

Study discussed with and explained to;

The nature and purpose of this study have been defined.
I
understand that all information will be kept confidential
and that this institution may withdraw at any time during
the data collection.

By _______________
Physician
Physician
Researcher
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Appendix E
Registration Slip

PLEASE PRINTI

REGISTRATION SLIP

Your Date of Birth

Your Name
Your Address

(State)

(City)

(Mailing Address)
Home Phone Number

(Zip Code

Work Phone Number

Your Social Security Number_

Husband's Name

Your Employer_______________

Husband's Employer_

Your Occupation

Husband's Occupation

Your next of kin (other than husband) and relationship to you_________
This relative's address____________________________ Their phone number
Who referred you to our doctors? (Please specify)_____________________
INSURANCE INFORMATION

**If you have an insurance card, please Let the receptionist copy it

Primary Insurance

Secondary Insurance

Insurance Co. Name_

Insurance Co. Name_

Insured's Name

Insured's Name

Insured's Social Security i_

Insured's Social Security f

Policy or ID <

Policy or ID ÿ_____________

Croup Number/Name__________

Group Number/Name__________

Benefits Phone Number

Benefits Phone Number

Pre-cert Phone Number_

Pre-cert Phone Number_

Mail Claims To:

Mail Claims To:

ASSIGNMENT OF BENEFITS/AUTHORIZATION TO RELEASE INFORMATION: I hereby authorize payment o!
insurance benefits payable to me but not to exceed the regular charges for the current yeai
directly to Oxford OB/GYN Associates, P.A. I understand that I am financially responsible
to Oxford OB/GYN Associates, P.A. for charges not covered by this authorization. I hereby
authorize Oxford OB/GYN Associates, P.A. to release medical information for the purposes oi
filing insurance claims with my insurance company (companies).

(Patient's signature/Parent's signature, if patient is
a minor)
Billing Addressdf different from Mailing Address)
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(Today's Date)

Appendix F
Patient Questionnaire

PATIENT QUESTIONNAIRE

Name________________________________________________________________________Date______________________
During the last year, your life may have changed and this may affect your health. Please help us to provide the best health
care for you by completing this short questionnaire.

Circle one

If yes, please specify

Have you changed your occupation?

Yes

No

__________________________________

Do you have any problems at home?

Yes

No

__________________________________

Has there been any change in your relationship
with your husband, partner, or boyfriend?

Yes

No

__________________________________

Has there been a change in your periods?

Yes

No

__________________________________

Yes

No

Do you use it regularly?_____________

Date of your last period?_________________
Do you use a method of contraception?
If yes, what type?
natural/rhythm

pills

lUD

sponge

diaphragm

spermicide

condoms

Are you/your partner satisfied with this

other_________

Do you want any information about birth control?

method?__________________________
Yes

No

__________________________________

Date of your last Pap test?_______________
Do you have any questions about safer s e x ?

Yes

No

____________________________ _— —

Do you smoke cigarettes?..........................................................

Yes

No

How many per day?_________________

Do you use street d ru g s ?

Yes

No

__________________________________

Do you drink alcohol?.................................................................

Yes

No

How often? How much?-----------------------

Have you ever felt the need to cut down on your drinking?.

Yes

No

__________________________ — --------

Are you exercising?.....................................................................

Yes

No

How often? What ty p e ? _____________

Have you had any illnesses?

Yes

No

________________________ ___— ------

Have you seen any of your other doctors recently?

Yes

Are you taking any medicines now?............................................
Have you ever had a cholesterol test?

Yes
Yes

No

__________________________________

No

__________________________ —------ — .

No

When?______________________ _— —

Please answer If you are over 39:
Date of your last mammogram?___________________
Date of your last stool test?_______________________
What brings you to our office today?

Do you have any questions, problems, or concerns that you would like to discuss with us today?
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Appendix G
GYN Cytology Report Form

4^%%^GYN ?qYTOLQGY REPORT
Patient:
Address:
Date of birth:
Age:
Sex:
Doctor:
Anatomical Source:
IM P:
Number of Slides:

Accession#:
Med Record#:
Social Security#:
Room#:
•HISTO RY/ADM ITTING DIAGNOSISDate of Specimen:
Date Received:
Date Reported:

Clinical History:

SPECIMEN ADEQUACY:

DESCRIPTIVE DIAGNOSIS:
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Appendix H
Pathology Report Form

Patient:
Address:

Accession U:

Date of Birth:
Age:
Sex:
Physician:

Med. Rec. #:
Social Security #
Room #:
Page:

1 of 1

History / Admitting Diagnosis
Date of Specimen:

Date Received:
Date Reported:

Clinical Data:
Postoperative
Diagnosis:
Anatomic Source:
GROSS DESCRIPTION:
A.

FINAL DIAGNOSIS:
A.
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Appendix I
Data Collection Sheet and Raw Data with Code Descriptions

Code Descriptions
Rand#

Random number assigned to case to assure
anonymity

RCE

Race

YOB

Year of Birth

AGE

Age at time of first ASCUS

ASCUS Date

Date of first ASCUS

ASCUS LMP

Date of last menstrual period at first ASCUS

HPV

Coded 1 if ASCUS suggestive of Human
Papillomavirus
Coded 0 if ASCUS not suggestive of Human
Papillomavirus

WRT

Coded 1 if genital warts are present
Coded 0 if genital warts are not present

SMK

Coded 1 if patient smokes
Coded 0 if patient does not smoke

BCM

Records the birth control method used
OCP
T
PM
X/UKN
NR
D
C
N

Oral Contraceptive Pills
Tubal Sterilization
Post-menopausal
None or unknown
Natural/rhythm
Diaphragm
Condoms
Norplant

CND

Candida noted on cytology report
Coded 1 if present

HSV

Herpes Simplex Virus noted on cytology report
Coded 1 if present

GC

Gonorrhea
Coded 1 if identified
80

81

BC

Bacteria noted on cytology report
Coded 1 if present

CHL

Chlamydia
Coded 1 if identified

BX Date

Date of colposcopically directed biopsy

LMP

Date of last menstrual period preceding biopsy

DX

Diagnosis coded 0 for negative biopsy
Diagnosis coded 1 for dysplasia on biopsy

L/H

Coded 0 for low grade SIL
Coded 1 for high grade SIL

BXH

Coded 1 for HPV on biopsy

BY

Coded 0 or 1 for physician identification
performing biopsy

PG

Coded 0 for not pregnant at time of index
smear
Coded 1 for pregnancy

#AS

Number of abnormal cytology reports held by
pathology laboratory including index smear
before biopsy

ELT

Elapsed time in days between index smear
biopsy
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